Back to Search

DANIEL J COY MD

MD

Pain Medicine (Anesthesiology) Physician

NPI: 1134213929Individual

Specialties, Licenses & Credentials

Anesthesiology Physician

Anesthesiology

Code: 207L00000X

0428274(KS)
Pain Medicine (Anesthesiology) PhysicianPrimary

Anesthesiology — Pain Medicine

Code: 207LP2900X

0428274(KS)

Research & Publications (20)

Reversible cytotoxic edema in a cirrhotic patient following TIPS.
PMID 19344367·J Neuroimaging·2009
5-case
Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors.
PMID 19463875·Peptides·2009
7-preclinical
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
PMID 18795252·Diabetologia·2008
7-preclinical
Involvement of VPAC1 and VPAC2 receptors in increasing local pancreatic blood flow in anesthetized rats.
PMID 18665096·Pancreas·2008
7-preclinical
Molecular basis for agonist selectivity and activation of the orphan bombesin receptor subtype 3 receptor.
PMID 18006692·J Pharmacol Exp Ther·2008
4-observational
Vasoactive intestinal peptide-camptothecin conjugates inhibit the proliferation of breast cancer cells.
PMID 17580098·Peptides·2007
7-preclinical
Effects of camptothecin on tumor cell proliferation and angiogenesis when coupled to a bombesin analog used as a targeted delivery vector.
PMID 17264768·Anticancer Drugs·2007
8-other
A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
PMID 16644105·Cancer Lett·2007
7-preclinical
Identification of bombesin receptor subtype-specific ligands: effect of N-methyl scanning, truncation, substitution, and evaluation of putative reported selective ligands.
PMID 16943256·J Pharmacol Exp Ther·2006
7-preclinical
In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors.
PMID 16766720·J Pharmacol Exp Ther·2006
7-preclinical
Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
PMID 16613992·Mol Endocrinol·2006
8-other
Somatostatin receptor subtypes mediate contractility on human colonic smooth muscle cells.
PMID 16487413·Neurogastroenterol Motil·2006
8-other
Somatostatin inhibits insulin release via SSTR2 in hamster clonal beta-cells and pancreatic islets.
PMID 15927701·Regul Pept·2005
7-preclinical
Development of simplified vasoactive intestinal peptide analogs with receptor selectivity and stability for human vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors.
PMID 15994369·J Pharmacol Exp Ther·2005
8-other
Camptothecin-somatostatin conjugates inhibit the growth of small cell lung cancer cells.
PMID 16112393·Peptides·2005
8-other
VIP attenuation of the severity of experimental pancreatitis is due to VPAC1 receptor-mediated inhibition of cytokine production.
PMID 15632701·Pancreas·2005
7-preclinical
Somatostatin-receptor 2 (sst2)-mediated effects of endogenous somatostatin on exocrine and endocrine secretion of the rat stomach.
PMID 15655503·Br J Pharmacol·2005
7-preclinical
Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
PMID 15670577·Biochem Pharmacol·2005
7-preclinical
The effect of drug dose and drug exposure time on the binding, internalization, and cytotoxicity of radiolabeled somatostatin analogs.
PMID 15126075·J Surg Res·2004
8-other
Development of high affinity camptothecin-bombesin conjugates that have targeted cytotoxicity for bombesin receptor-containing tumor cells.
PMID 15016826·J Biol Chem·2004
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
8101 W 135TH ST, SUITE 200
OVERLAND PARK, KS 66223
Practice locations map

Location

THE HEADACHE & PAIN CENTER, P.A.

8101 W 135TH ST, OVERLAND PARK, KS
(913) 491-3999

Quick Facts

NPI
1134213929
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile